Sign in Pull a receipt

NRIX

Nurix Therapeutics, Inc.

Healthcare · Biotechnology

$47.72 sample

-0.11 (-0.23%) 1D

Market cap

$60.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-24

Alerts

8

Price$47.72 -3.17% 3M daily closessample

51.4047.31

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Director
Oct 22INSInsider sell: Chief Financial Officer
Oct 15INSInsider sell: Chief Financial Officer
Oct 08INSInsider sell: General Counsel
Sep 30INSInsider buy: Chief Executive Officer
Sep 24SEC10-Q filed
Sep 15SECDEF 14A filed
Sep 10INSInsider sell: General Counsel

Sign up to see the real NRIX record →

Company facts

SEC EDGAR registration

Name: Nurix Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +49sample, -100 to +100
Reporting currency: USD

Who is positioning in NRIX

sample

Insiders: 7 insider transactions over 90 days, net selling, $642.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 36 funds hold $637.2M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.5B +16.0% y/y

Q4 2024Q3 2026

Inventory$2.0B +16.5% y/y

Q4 2024Q3 2026

Accounts receivable$1.5B +7.7% y/y

Q4 2024Q3 2026

Total debt$4.1B +16.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $26.7B +2.9% 3M
Sample peer B: $10.6B +16.2% 3M
Sample peer C: $24.0B +0.4% 3M
Sample peer D: $57.7B +1.2% 3M
Sample peer E: $12.2B -5.4% 3M